Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Trinity Bio ADR (TRIB)

5.11 -0.01 (-0.20%)

10/20/2017  4:00pm

Open:

5.13

Pre. Close:

5.12

High:

5.19

Low:

5.10

Volume:

28,520

Market Cap:

111.64M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.23 - 5.29

5.29 - 5.35

Low:

4.97 - 5

5 - 5.03

Close:

5.03 - 5.11

5.11 - 5.2

Technical analysis  (as of: 2017-10-20 4:41:51 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 6.41     One year: 6.70

Support:

Support1: 5.09    Support2: 4.23

Resistance:

Resistance1: 5.49    Resistance2: 5.74

Pivot:

5.29

Moving Averages:

MA(5): 5.20     MA(20): 5.37

MA(100): 5.61     MA(250): 5.98

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 10.90     %D(3): 17.96

RSI:

RSI(14): 36.55

52-Week:

High: 7.40  Low: 5.09  Change(%): -27.2

Average Vol(K):

3-Month: 3762  10-Days 1428

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TRIB has closed above bottom band by 10.3%. Bollinger Bands are 15.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 07 Jul 2009 13:44:26 GMT
5.13

Fri, 11 Feb 2011 14:48:10 GMT
Trinity Biotech PLC ADR

Tue, 17 Oct 2017 22:18:45 GMT
EPS for Trinity Biotech plc (ADR) (TRIB) Expected At $0.03

Tue, 04 Oct 2016 16:07:30 GMT
Trinity Biotech Plummets 50%: Here's What You Need To Know

Thu, 27 Apr 2017 12:00:00 GMT
Trinity Biotech Announces Results for Q1, 2017

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Diagnostic Testing Substances Manufacturers

Shares Out. (M)

21.00

Shares Float (M)

20.50

% Held by Insiders

5.95

% Held by Institutions

63.64

Shares Short (K)

588

Shares Short Prior Month (K)

605

Stock Financials

EPS

-4.430

EPS Est. Current Year

0.270

EPS Est. Next Year

0.330

EPS Est. Next Quarter

0.080

Forward EPS

0.330

Book Value (p.s.)

4.890

PEG Ratio

1.31

Profit Margin

-100.45

Operating Margin

2.52

Return on Assets (ttm)

0.5

Return on Equity (ttm)

-23.4

Qtrly Rev. Growth

-3.2

Gross Profit (p.s.)

1.688

Sales Per Share

4.704

EBITDA (p.s.)

0.352

Qtrly Earnings Growth

-57.10

Operating Cash Flow (M)

9.73

Levered Free Cash Flow (M)

0.02

FoxReading.com

Valuation

P/E

-1.15

P/E Growth Ratio

P/BV

1.04

P/S

1.09

P/CF

11.03

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2015-01-07

Ex-Dividend Date

2015-05-06

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.